image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Energean

November 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ENOG
  • Price:
  • 957p
Half year results for Energean showed adjusted cash profit before exploration (EBITDAX) rising 41% to US$23.6m on sales up 52% to US$40m with production up 3% to 3,920 barrels oil equivalent per day. For the full year guidance is for 3,400-3,3600 barrels.The original growth story is that Energean has legacy production assets in Greece and gas fields at Karish and Tanin in Israel, which could exponentially increase production and the latter are still on track for first gas in Q1 2021. The recent Karish North discovery and other upcoming drilling opportunities could also add a further 10 trillion cubic feet gas to reserves and resources.But even this opportunity in Israel has been overshadowed by the huge US$750m upfront acquis ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X